Last $2.70 USD
Change Today +0.05 / 1.89%
Volume 344.7K
ATRS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Eamonn P. Hobbs

Chief Executive Officer, President, Director, Member of Audit Committee and Member of Governance & Nominating Committee, Antares Pharma Inc.
AgeTotal Calculated CompensationThis person is connected to 54 board members in 6 different organizations across 8 different industries.

See Board Relationships
56$143,545

Background*

Mr. Eamonn P. Hobbs has been the Chief Executive Officer and President of Antares Pharma Inc. since June 2014. Mr. Hobbs served as the Chief Executive Officer and President of Delcath Systems, Inc. from July 2009 to September 10, 2013. He Co-founded AngioDynamics Inc., a subsidiary of E-Z-EM Inc. and served as its Chief Executive Officer and President from June 1996 to March 1, 2009. He served as Senior Vice President of Angio Dynamics since October 2002 and its Vice ...

Read Full Background

Corporate Headquarters*

100 Princeton South
Ewing, New Jersey 08628

United States

Phone: 609-359-3020
Fax: --

Board Members Memberships*

Former Vice Chairman of the Board
Vice Chairman
Board Chair
Director
Former Chairman
2008-2013
Former Chief Executive Officer, President and Director
2009-Present
Chief Executive Officer, President, Director, Member of Audit Committee and Member of Governance & Nominating Committee
2010-Present
Chairman
2014-Present
Chairman

Education*

BS 1980
University of Massachusetts Lowell

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$33,544
Total Calculated Compensation$143,545
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATRS:US $2.70 USD +0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William M. Greenman Chief Executive Officer, President and Director
Cerus Corporation
$495.8K
Barry G. Caldwell Chief Executive Officer, President and Director
STAAR Surgical Company
$638.3K
Jeffrey M. Nugent Chief Executive Officer, President, Director and Member of Finance Committee
BIOLASE, Inc.
--
Gary R. Maharaj Chief Executive Officer, President and Director
SurModics, Inc.
$443.7K
Zami Aberman Executive Chairman and Chief Executive Officer
Pluristem Therapeutics, Inc.
$503.7K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANTARES PHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.